🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users injecting substances of uncertain source.

Several professionals stated the demand for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Response and Material Removal

According to the social media company, the platform has taken down problematic content and prohibited associated hashtags and query recommendations. The company said it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.

After moments of entering one community, a vendor shared contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Product Details and Pricing

Inside these groups, messages show black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to possibly serious medical dangers”.